| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |